CHRS - Coherus Oncology, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$6.02
DETAILS
HIGH:
$11.00
LOW:
$1.05
MEDIAN:
$6.00
CONSENSUS:
$6.02
UPSIDE:
273.91%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Revenue | 42.2 | 267.0 | 257.2 | 211.0 | 326.6 | 475.8 | 356.1 | 1.6 | 1.6 | 190.1 | 30.0 | 31.1 | 2.8 | 1.9 |
| Cost of Revenue | 17.7 | 117.6 | 159.0 | 70.1 | 57.6 | 37.7 | 17.1 | 3.2 | 160.5 | 254.4 | 212.7 | 78.2 | 31.3 | 34.9 |
| Gross Profit | 24.4 | 149.4 | 98.3 | 141.0 | 269.0 | 438.2 | 339.0 | (1.7) | (159.0) | (64.3) | (182.6) | (47.1) | (28.5) | (33.0) |
| Operating Expenses | ||||||||||||||
| R&D Expenses | 105.0 | 93.3 | 109.4 | 199.4 | 363.1 | 142.8 | 94.2 | 110.2 | 162.4 | 254.4 | 213.1 | 78.2 | 31.3 | 34.9 |
| SG&A Expenses | 99.0 | 150.4 | 185.6 | 198.5 | 169.7 | 139.1 | 137.0 | 94.2 | 71.3 | 51.6 | 36.0 | 17.6 | 7.5 | 5.5 |
| Other Expenses | 0 | 17.3 | 6.4 | 0 | 0 | 0 | 0 | 4.7 | 3.4 | (3.9) | (4.8) | (18.6) | (12.3) | 7.0 |
| Operating Expenses | 204.0 | 261.1 | 301.5 | 397.8 | 532.8 | 281.8 | 231.2 | 204.4 | 233.7 | 306.0 | 249.1 | 95.8 | 38.7 | 40.4 |
| Operating Income | ||||||||||||||
| Operating Income | (179.5) | (111.7) | (203.2) | (256.9) | (263.9) | 156.3 | 107.8 | (204.4) | (232.1) | (115.9) | (219.1) | (64.7) | (36.0) | (38.5) |
| Interest Expense | 9.0 | 27.2 | 40.5 | 32.5 | 23.0 | 21.2 | 17.6 | 9.7 | 9.6 | 8.0 | 0.0 | 3.9 | 5.3 | 1.5 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profitability | ||||||||||||||
| EBITDA | (175.6) | 60.9 | (193.9) | (255.6) | (260.7) | 161.8 | 111.0 | (204.4) | (225.3) | (116.8) | (222.0) | (82.7) | (47.9) | (31.3) |
| EBIT | (179.5) | 55.7 | (197.7) | (259.3) | (264.1) | 156.9 | 107.8 | (200.6) | (228.7) | (119.8) | (223.9) | (83.4) | (48.3) | (31.5) |
| Income Before Tax | (183.1) | 28.5 | (238.3) | (291.8) | (287.1) | 135.7 | 92.8 | (209.4) | (238.3) | (127.8) | (223.9) | (87.2) | (53.6) | (33.0) |
| Income Tax Expense | 0 | 0 | (0.4) | 0 | 0 | 3.5 | 2.9 | 0 | 0 | 0.7 | 0 | 0 | 0 | 0 |
| Net Income | (170.3) | 28.5 | (237.9) | (291.8) | (287.1) | 132.2 | 89.8 | (209.3) | (238.2) | (127.3) | (223.3) | (87.1) | (53.6) | (33.0) |
| Per Share Data | ||||||||||||||
| EPS (Basic) | -1.45 | 0.25 | -2.53 | -3.76 | -3.81 | 1.85 | 1.29 | -3.22 | -4.48 | -3.04 | -6.01 | -10.64 | -2.97 | -11.69 |
| EPS (Diluted) | -1.45 | 0.25 | -2.53 | -3.76 | -3.81 | 1.62 | 1.23 | -3.22 | -4.48 | -3.04 | -6.01 | -10.64 | -2.97 | -11.69 |
| Shares Outstanding | 120.4 | 114.6 | 94.2 | 77.6 | 75.4 | 71.4 | 69.7 | 65.0 | 53.1 | 41.9 | 37.1 | 8.2 | 18.1 | 2.8 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 88.9 | 126.0 | 102.9 | 63.5 | 417.2 | 541.2 | 177.7 | 72.4 | 126.9 | 124.9 |
| Short-Term Investments | 83.2 | 0 | 14.9 | 128.1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 18.4 | 122.3 | 260.5 | 110.0 | 123.0 | 157.0 | 142.0 | 0 | 0 | 1.9 |
| Inventory | 3.2 | 70.1 | 62.6 | 38.8 | 37.6 | 44.2 | 9.8 | 1.7 | 0 | (4.8) |
| Other Current Assets | 6.2 | 11.5 | 11.1 | 22.9 | 10.8 | 0 | 0 | 0.1 | 0.2 | 3.0 |
| Total Current Assets | 206.7 | 341.6 | 475.6 | 381.2 | 602.3 | 767.5 | 343.0 | 72.4 | 126.9 | 124.9 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 1.3 | 2.8 | 5.1 | 8.8 | 7.8 | 10.1 | 16.5 | 6.7 | 12.8 | 10.8 |
| Goodwill | 0 | 0 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 |
| Intangible Assets | 46.2 | 53.6 | 70.7 | 5.0 | 2.6 | 2.6 | 2.6 | 2.6 | 2.6 | 2.6 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.8 | 0.8 | 0.8 |
| Other Non-Current Assets | 4.1 | 50.5 | 77.2 | 84.9 | 65.6 | 60.5 | 45.9 | 16.9 | 19.4 | 39.2 |
| Total Non-Current Assets | 51.6 | 107.0 | 154.0 | 99.6 | 77.0 | 74.2 | 65.9 | 27.1 | 35.7 | 53.5 |
| Total Assets | 258.3 | 448.5 | 629.6 | 480.8 | 679.3 | 841.6 | 408.9 | 99.5 | 162.6 | 178.5 |
| Current Liabilities | ||||||||||
| Account Payables | 9.9 | 28.5 | 35.2 | 11.5 | 16.2 | 15.2 | 26.0 | 15.3 | 15.7 | 20.6 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.8 | 2.0 |
| Other Current Liabilities | 16.1 | 33.1 | 21.5 | 22.6 | 22.0 | 22.2 | 20.6 | 0.4 | 3.6 | 26.9 |
| Total Current Liabilities | 141.9 | 283.0 | 331.8 | 138.7 | 165.3 | 145.7 | 115.0 | 33.3 | 28.4 | 56.4 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 37.1 | 264.9 | 473.4 | 471.1 | 408.3 | 404.0 | 178.4 | 103.1 | 101.6 | 100.3 |
| Deferred Tax Liabilities | 1.1 | 1.1 | 1.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 15.8 | 28.2 | 11.5 | 3.5 | 0.8 | 1.1 | 0.1 | 1.7 | 2.1 | 1.8 |
| Total Non-Current Liabilities | 55.5 | 297.5 | 491.3 | 479.6 | 416.3 | 415.0 | 188.7 | 138.1 | 132.1 | 159.1 |
| Total Liabilities | 197.3 | 580.5 | 823.0 | 618.3 | 581.6 | 560.7 | 303.7 | 138.1 | 132.1 | 159.1 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (1,383.0) | (1,551.0) | (1,579.5) | (1,341.6) | (1,049.9) | (762.8) | (895.0) | (984.8) | (775.5) | (537.3) |
| Accumulated Other Comprehensive Income | (0.2) | (0.3) | (0.2) | (0.2) | (0.3) | (0.3) | (0.6) | (0.3) | (0.8) | (0.6) |
| Total Stockholders' Equity | 61.0 | (132.0) | (193.4) | (137.4) | 97.7 | 281.0 | 105.2 | (38.6) | 30.5 | 19.4 |
| Total Liabilities & Equity | 258.3 | 448.5 | 629.6 | 480.8 | 679.3 | 841.6 | 408.9 | 99.5 | 162.6 | 178.5 |
| Debt Metrics | ||||||||||
| Total Debt | 40.3 | 269.9 | 480.8 | 480.4 | 419.0 | 417.1 | 188.6 | 103.1 | 101.4 | 100.3 |
| Net Debt | (48.5) | 143.9 | 378.0 | 416.9 | 1.8 | (124.1) | 11.0 | 30.7 | (25.5) | (24.7) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | 168.0 | 28.5 | (237.9) | (291.8) | (287.1) | 132.2 | 89.8 | (209.4) | (238.3) | (127.8) |
| Depreciation & Amortization | 0 | 5.3 | 3.8 | 3.7 | 3.5 | 2.9 | 3.3 | 3.2 | 3.4 | 3.0 |
| Stock-Based Compensation | 0 | 27.8 | 43.1 | 50.7 | 51.4 | 38.2 | 33.6 | 34.8 | 36.1 | 27.4 |
| Change in Working Capital | (5.8) | 55.9 | (36.8) | (79.3) | 42.4 | (34.7) | (113.9) | 10.3 | (5.1) | (159.2) |
| Other Non-Cash Items | (300.7) | (137.9) | 52.9 | 75.5 | 143.1 | 15.5 | 15.7 | (1.7) | 3.2 | 5.3 |
| Operating Cash Flow | (138.5) | (20.4) | (174.9) | (241.1) | (37.4) | 154.1 | 28.4 | (159.3) | (200.3) | (252.5) |
| Investing Activities | ||||||||||
| Capital Expenditure | 0 | 0 | (0.3) | (2.0) | (1.3) | (7.2) | (12.9) | (0.8) | (4.6) | (6.5) |
| Acquisitions | 0 | 0 | 0.8 | 0 | 1.3 | 0 | 1.7 | (0.7) | 0 | 0 |
| Purchases of Investments | (103.8) | 0 | (19.5) | (127.4) | (182.5) | (273.8) | (20.2) | (42.9) | (74.3) | 0 |
| Sales/Maturities of Investments | 21.5 | 14.9 | 157.6 | 0 | 181.4 | 274 | 20.4 | 43.2 | 74.5 | 0 |
| Other Investing Activities | 457.5 | 215.4 | 5.9 | (37.4) | (137.3) | (7.3) | (1.7) | 0.3 | 0.2 | (6.5) |
| Investing Cash Flow | 375.1 | 230.3 | 144.6 | (166.8) | (138.4) | (14.4) | (12.7) | (1.2) | (4.4) | (6.5) |
| Financing Activities | ||||||||||
| Net Debt Issuance | (233.2) | (223.4) | 0 | 49.9 | (0.7) | 222.2 | 73.0 | 0 | 0 | 100 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.5) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (48.8) | 35.0 | (4.6) | (2.0) | 54.3 | 1.8 | 8.3 | 3.7 | 0.5 | 2.6 |
| Financing Cash Flow | (273.7) | (187.0) | 69.6 | 54.3 | 51.9 | 223.9 | 89.4 | 105.4 | 206.8 | 226.2 |
| Cash Position | ||||||||||
| Net Change in Cash | (37.1) | 22.9 | 39.3 | (353.6) | (124.0) | 363.7 | 104.7 | (54.6) | 2.0 | (33.3) |
| Cash at Beginning | 126.2 | 103.3 | 63.5 | 417.6 | 541.6 | 177.9 | 73.2 | 127.8 | 124.9 | 158.2 |
| Cash at End | 89.1 | 126.2 | 102.9 | 64.0 | 417.6 | 541.6 | 177.9 | 73.2 | 126.9 | 124.9 |
| Free Cash Flow | (138.5) | (20.4) | (175.2) | (243.2) | (38.7) | 146.9 | 15.5 | (160.1) | (204.9) | (259.1) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||
| Revenue | 42.2 | 267.0 | 257.2 | 211.0 | 326.6 | 475.8 | 356.1 | 1.6 | 1.6 | 190.1 | 30.0 | 31.1 | 2.8 | 1.9 |
| Gross Profit | 24.4 | 149.4 | 98.3 | 141.0 | 269.0 | 438.2 | 339.0 | (1.7) | (159.0) | (64.3) | (182.6) | (47.1) | (28.5) | (33.0) |
| Operating Income | (179.5) | (111.7) | (203.2) | (256.9) | (263.9) | 156.3 | 107.8 | (204.4) | (232.1) | (115.9) | (219.1) | (64.7) | (36.0) | (38.5) |
| Net Income | (170.3) | 28.5 | (237.9) | (291.8) | (287.1) | 132.2 | 89.8 | (209.3) | (238.2) | (127.3) | (223.3) | (87.1) | (53.6) | (33.0) |
| EPS (Diluted) | -1.45 | 0.25 | -2.53 | -3.76 | -3.81 | 1.62 | 1.23 | -3.22 | -4.48 | -3.04 | -6.01 | -10.64 | -2.97 | -11.69 |
| Balance Sheet | ||||||||||||||
| Cash & Equivalents | 88.9 | 126.0 | 102.9 | 63.5 | 417.2 | 541.2 | 177.7 | 72.4 | 126.9 | 124.9 | ||||
| Total Assets | 258.3 | 448.5 | 629.6 | 480.8 | 679.3 | 841.6 | 408.9 | 99.5 | 162.6 | 178.5 | ||||
| Total Debt | 40.3 | 269.9 | 480.8 | 480.4 | 419.0 | 417.1 | 188.6 | 103.1 | 101.4 | 100.3 | ||||
| Stockholders' Equity | 61.0 | (132.0) | (193.4) | (137.4) | 97.7 | 281.0 | 105.2 | (38.6) | 30.5 | 19.4 | ||||
| Cash Flow | ||||||||||||||
| Operating Cash Flow | (138.5) | (20.4) | (174.9) | (241.1) | (37.4) | 154.1 | 28.4 | (159.3) | (200.3) | (252.5) | ||||
| Capital Expenditure | 0 | 0 | (0.3) | (2.0) | (1.3) | (7.2) | (12.9) | (0.8) | (4.6) | (6.5) | ||||
| Free Cash Flow | (138.5) | (20.4) | (175.2) | (243.2) | (38.7) | 146.9 | 15.5 | (160.1) | (204.9) | (259.1) | ||||